Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/15/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/12/17 | 8-K | Current report filing |
|
4 | |
| 06/06/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/25/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/19/17 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
8 | |
| 05/19/17 | 8-K/A | Current report filing |
|
4 | |
| 05/19/17 | 8-K/A | Current report filing |
|
4 | |
| 05/18/17 | 8-K | Current report filing |
|
7 | |
| 05/18/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |